![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4316|12|10|1707-1714
ISSN: 1389-2010
Source: Current Pharmaceutical Biotechnology, Vol.12, Iss.10, 2011-10, pp. : 1707-1714
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CX3CR1 as a target for airways inflammation
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 9, 2011-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The CX3C-Chemokine Fractalkine in Kidney Diseases
Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
Current Gene Therapy, Vol. 17, Iss. 6, 2018-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Boddeke E.W.G.M. Meigel I. Frentzel S. Biber K. Renn L.Q. Gebicke-Harter P.
European Journal of Pharmacology, Vol. 374, Iss. 2, 1999-06 ,pp. :